Document is current
Any future updates will be listed below
-
Authors
Knobbe, Tim J.
Kremer, Daan
Eisenga, Michele F.
Corpeleijn, Eva
Annema, Coby
Spikman, Joke M.
,
Annema, Coby
Bakker, Stephan J. L.
Berger, Stefan P.
Blokzijl, Hans
Bodewes, Frank
de Boer, Marieke T.
Damman, Kevin
de Borst, Martin H.
Diepstra, Arjan
Dijkstra, Gerard
Douwes, Rianne M.
Eisenga, Michele F.
Erasmus, Michiel E.
Tji Gan, C.
Gomes Neto, Antonio W.
Grootjans, Heleen
Hak, Eelko
Rebecca Heiner-Fokkema, M.
Hepkema, Bouke G.
Klont, Frank
Knobbe, Tim J.
Kremer, Daan
Leuvenink, Henri G. D.
Lexmond, Willem S.
de Meijer, Vincent E.
Niesters, Hubert G. M.
van Pelt, L. Joost
Pol, Robert J.
Porte, Robert J.
Ranchor, Adelita V.
Sanders, Jan Stephan F.
Schutten, Joëlle C.
Siebelink, Marion J.
Slart, Riemer J. H. J. A.
Casper Swarte, J.
Timens, Wim
Touw, Daan J.
van den Heuvel, Marius C.
van Leer-Buter, Coretta C.
van Londen, Marco
Verschuuren, Erik A. M.
Vos, Michel J.
Weersma, Rinse K.
Navis, Gerjan
Berger, Stefan P.
Bakker, Stephan J. L.
-
Funding
Funding for this research was provided by:
Chiesi
Astellas BV (TransplantLines Biobank and Cohort study, TransplantLines Biobank and Cohort study, TransplantLines Biobank and Cohort study)
Vifor Pharma
Nierstichting
Novartis
- License Information
-
More Information
Article History
Received: 11 October 2021
Accepted: 7 September 2022
First Online: 28 September 2022
Competing interests
: The authors declare no competing interests.
